MedPage Today on MSN3d
Dementia-Shingles Vax Study; ALS Cluster Spotted; Why Dementia Tsunami May Subside
Sen. Tammy Baldwin (D-Wis.) and Sen. Peter Welch (D-Vt.) will host a forum on Wednesday, March 26, to discuss how delayed NIH ...
Mother with rare ALS touts 'miracle drug' that has stopped her disease
Raziel Green, 52, an active runner and mother of two, was diagnosed with a rare form of ALS in 2017. Since starting a ...
Yahoo Finance16d
39 members of the Canadian ALS community honoured with King Charles III Coronation Medal
ALS community advocate and volunteer Dr. Heather Durham (British Columbia) – Professor Emerita, Department of Neurology and Neurosurgery and Montreal Neurological Institute, McGill University Dr ...
EL PAÍS English13d
A devastating nerve disease stalks a mountain village
Neurologists have grappled with a cluster of amyotrophic lateral sclerosis cases in France, where a fondness for a toxic wild ...
Clene Reports Full Year 2024 Financial Results and Recent Operating Highlights
Clene planning to submit a New Drug Application (NDA) in the second half of 2025 for potential Accelerated Approval of CNM-Au8® in ALSClene ...
The Jerusalem Post Blogs27d
NeuroSense’s ALS drug PrimeC shows success in phase 2b, eyes final trial
which is the current gold-standard scale used in ALS drug development," The Chair of Neurology and Director of the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital Merit ...
Hosted on MSN29d
Blood Test Can Help Diagnose, Track ALS
researchers reported Feb. 26 in the journal Neurology. A blood test looking for neurofilament light chain proteins accurately identified ALS patients more than 80% of the time, researchers said.
PipelineReview.com4d
SineuGene Therapeutics Announces FDA IND Clearance for SNUG01, a First-in-Class TRIM72-Targeted Gene Therapy for ALS
BEIJING, China I March 24, 2025 I SineuGene Therapeutics Co., Ltd. ("SineuGene"), a clinical-stage biotech company pioneering innovative therapies for ...